Jim Von Ehr is the Founder of Zyvex Labs, LLC. He is also Chairman of the Board of Teliatry,. and Managing Director of Zycraft Pte. Ltd. (Singapore) and Gray Tiger Holdings Ltd. (Hong Kong). Before founding Zyvex Corporation in 1997, Jim was the founder, president, chairman and CEO of Altsys Corporation, which developed FreeHand and Fontographer, the first commercially available PostScript drawing program. Altsys was sold to Macromedia in 1995, where he held a seat on the Board of Directors for nearly four years.

In 2003, Jim testified before the Senate Committee on Commerce, Science, and Transportation for Bill S.189 (The 21st Century Nanotechnology Research and Development Act) and was invited to the Oval Office to be present when President Bush signed the Bill into law on December 3, 2003. He was also an invited member of the Nanotechnology Technical Advisory Group (NTAG) to the U.S. President’s Council of Advisors on Science and Technology (PCAST).

Jim received Ernst & Young’s Entrepreneur of the Year Award (2003), the Ernest Randall Economic Development Leadership Award from the Richardson (Texas) Chamber of Commerce (2004), Richardson’s Citizen of the Year (2008), and Tech America’s “Texas Legend” award (2009).

Jim has a BS in Computer Science from Michigan State University and an MS in Mathematical Sciences (Computer Science) from the University of Texas at Dallas. In 2004, he was awarded Distinguished Alumni awards from both universities and in 2006 he was awarded the Computer Science and Engineering Distinguished Alumni Award and the Claud Erickson Award (Michigan State University’s highest Engineering Alumni award).

Rahul co-founded Teliatry in 2018 with a vision to disrupt the Active implantable medical device manufacturing. A pioneer in miniaturization and microsystems design, he is the system architect of multiple active implants including the smallest, most complex active implant in the world, the NR600TM-Bionic eye, an innovation to heal the blind. He is also the system architect of the smallest, implantable Vagus Nerve Stimulator for targeted plasticity of brain that has received three FDA IDE approvals for the indications of Spinal cord injury, Stroke rehabilitation, and PTSD.

Rahul is currently the Director of Microsystems & Biosystems at Zyvex Labs and also the Director of MEMS at Nanoretina Inc. He has also been adjunct Professor at University of Texas at Arlington. Besides being a performer on various projects for NASA, DOE, NSA, DARPA, and DOD, Rahul has been PI on two DARPA programs to build the world’s smallest electron and ion microcolumn, respectively. He is currently the PI on two DARPA sub-awards for developing non-invasive Brain-Machine Interface (DARPA N3) and Bridging the Gap (DARPA BG+) between brain and the body for spinal cord injury patients.

Rahul has a BTech in Aerospace Engineering from the Indian Institute of Technology, Mumbai and an MS in Aerospace & Engineering Mechanics from the University of Florida. He has over 25 published articles and more than 10 patents awarded/pending in his name. He also won the Tech Titans Technology Inventors award in 2018.

Dr. Krishnan Chakravarthy, MD, PhD, is an anesthesiologist who specializes in multi-modal pain management. He completed fellowship training in pain management at Harvard Medical School and at Massachusetts General Hospital, and residency training in anesthesiology at Johns Hopkins School of Medicine, The Johns Hopkins Hospital. Dr. Chakravarthy earned his medical and doctorate degree from the University at Buffalo School of Medicine and Biomedical Sciences. He is also an Assistant Professor in the Department of Anesthesiology, and Affiliate Professor in the Department of Nanoengineering at UC San Diego School of Medicine.

His research interests include incorporating new technology into advancing pain care. This includes advancing the field of neuromodulation as well as using nanotechnology to develop new therapeutics and point of care device platforms to manage chronic pain. His research work has been featured in national and international venues and has been published in top journals, including Anesthesiology, Proceedings of the National Academy of Sciences, and Pain.

Dr. Chakravarthy currently serves on the editorial board of several national and international peer-reviewed journals, and committees on organizations such as the International Neuromodulation Society, and American Society of Pain and Neuroscience. An entrepreneur, Dr. Chakravarthy is a founder of several biotechnology startup companies focusing on applications of nanotechnology in the pain space, and novel small molecule therapeutic development to advance pain care, and advanced neuromodulation solutions.

Dr. Dane Grasse is a co-founder and the Chief Technology Officer at Teliatry, where he is developing the next generation of miniature wireless implantable neuromodulation and sensing devices. Dane has over 10 years of experience in designing, testing, and manufacturing wireless neural interface devices for research and medical use. His expertise is in low-power, miniaturized electrical systems for implantable devices, wireless power transfer technology, and implantable RF antenna design.

Dane received his Ph.D. in biomedical engineering from Drexel University where he conducted research into seizure prediction and prevention using neuronal firing patterns. After his graduate training he transitioned into industry as a research scientist employed by Triangle Biosystems, during which time he developed the company’s first wireless power transfer system for animal electrophysiology research. Before forming Teliatry, Dane was employed by the Texas Biomedical Device Center where he conducted research into neural interface technologies and led the electrical systems development of Teliatry’s VNS IPG.

While continuing as CEO of Zyvex Labs, John is Executive VP at Teliatry. John joined Zyvex Labs in March, 2001. Prior to Zyvex, John spent 15 years with Texas Instruments (TI) where he worked in high resolution processing for integrated circuits, MEMS, and quantum effect devices and also worked at MIT’s Lincoln Laboratory on ion beam and x-ray lithography. John is Executive VP at NanoRetina and currently lends his 30+ years of experience in micro- and nano-fabrication to his roles as Adjunct Professor at UT Dallas and Fellow of the AVS and IEEE. He has attracted over $38M in research contracts to Zyvex and resulting products have grossed over $80M. John has 104 published articles, more than 50 conference proceedings and other publications (>3300 citations) and 29 issued US Patents (>700 citations).

John has a B.S. (1975), M.S. (1977), PhD (1981) in Electrical Engineering from the University of Houston.

Tab Ashwill has a Bachelor’s degree in Global Business Management from the University of Phoenix. Since 1983, he has worked in the service, manufacturing and quality management fields. Tab Ashwill has over 30 years working in the ISO9001 field and is qualified as Lead Auditor for ISO9001, Aerospace AS9100D, and Medical Device 13485 quality management systems. He is a Lean Practitioner and a Six-Sigma Black Belt. He is also a Patent recipient for original equipment designs.

Dr. Vishnoukumaar Sivaji is a Biomedical R&D engineer at Teliatry. He is responsible for circuit design, embedded programming, and software for the next generation of wireless implantable medical devices. He has over 5 years of experience in designing and testing low power neuromodulation devices for research and medical use.

Vishnou has a Medical degree from Pondicherry University in India. He obtained his PhD in Biomedical Engineering from The University of Texas at Dallas, where his research was focused on developing wireless devices for peripheral nerve stimulation and recording. Following graduation, he worked at the Texas Biomedical Device Center, developing the hardware and software for Teliatry's VNS system and supported the efforts to get the device approved for clinical trials.

Bill joined Zyvex Labs in 2011 to assist in the research of Atomically Precise Manufacturing by building and operating Zyvex’s multiple STMs, as well as other various machines. In 2016 he transitioned to the Micro and Biosystems side of the company to assist with testing and inspecting Nano Retina’s active implantable bionic eye. He also began proof of concept testing for the Rapid Molecular Diagnostic platform to quickly and accurately diagnose viruses and bacteria at the DNA level. Bill is a stakeholder and founding member of Teliatry. As the Operations Manager, he is overseeing the assembly and production of the miniaturized IPGs (Implantable Pulse Generators) platform for advanced neuromodulation therapies such as Spinal Cord Injury (SCI), PTSD, Chronic Pain, Stroke and many more.

Bill has a background in LASER Electro-Optics, Vacuum Technology and Biomedical Equipment. He worked for LLNL (Lawrence Livermore National Laboratory) on the AVLIS (Atomic Vapor Laser Isotope Separation) program enriching uranium for nuclear power plants. He also worked for a successful start-up telecom company, ONI Systems, as the company’s engineering liaison between the optical engineering and manufacturing teams, bringing concepts and products to life.

Barbara joined Zyvex in 2005 as an Accounting Assistant and is currently Accounting/HR Manager for both Teliatry and Zyvex Labs. Her responsibilities include hiring, benefits, policies, payroll, open enrollments, 401(k) contribution management and government grant accounting, including voucher submission and government accounting audits, buyer and price negotiator, and accounts receivable/payable. Prior to joining Zyvex, Barbara worked in financial planning, tax preparation, client investment management and all phases of general accounting. She also served as a financial analyst in the cost reduction and employee suggestion department at General Dynamics, now Lockheed Martin, working on a team to save the company millions of dollars.

Barbara has a BA from the University of California, Irvine.